Cardiology and COVID-19: do we have sufficient information?

Related Experiment Video

Updated: Dec 3, 2025

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
06:16

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease

Published on: August 9, 2024

689

Nikita Garg1, Brendan McClafferty2, Devyani Ramgobin3

  • 1Lady Hardinge Medical College, New Delhi, Delhi 110001, India.

Future Cardiology
|October 30, 2020
PubMed

Insights

Severe acute respiratory syndrome coronavirus 2 (COVID-19) impacts cardiology, causing cardiovascular injury. Patients with COVID-19 and heart issues face worse outcomes, necessitating prompt diagnosis and intervention.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Public Health

Background:

  • The global COVID-19 pandemic, caused by SARS-CoV-2, presents significant challenges to healthcare systems worldwide.
  • Clinicians face a steep learning curve due to the virus's rapid spread and diverse clinical manifestations.
  • Cardiovascular complications are a notable concern in COVID-19 patients.

Purpose of the Study:

  • To detail the cardiovascular manifestations of COVID-19.
  • To explore the proposed pathophysiology, clinical signs, symptoms, and treatments for COVID-19-related cardiovascular disease.
  • To review the outcomes of cardiovascular injury in COVID-19 patients.

Main Methods:

  • Literature review and synthesis of current evidence on COVID-19 and cardiovascular disease.
  • Analysis of reported cases and clinical studies focusing on cardiac involvement in COVID-19.
  • Examination of proposed pathophysiological mechanisms linking SARS-CoV-2 infection to cardiovascular injury.

Main Results:

  • COVID-19 patients with cardiovascular injury exhibit a shorter time from symptom onset to clinical deterioration.
  • Higher mortality rates are observed in COVID-19 patients with cardiovascular complications.
  • Cardiovascular complications are more prevalent in older COVID-19 patient populations.

Conclusions:

  • Cardiovascular injury is a significant complication of COVID-19, associated with poorer prognosis.
  • Prompt diagnosis and intervention are critical for managing COVID-19 patients with pre-existing cardiovascular comorbidities.
  • Further research is needed to fully understand and manage the long-term cardiovascular sequelae of COVID-19.

Keywords:
ACE-2COVID-19SARS-CoV-2cardiology

More Related Videos

Author Spotlight: Workflow for Integrating POCUS Data into EHR for Managing Heart Failure Patients03:47

Author Spotlight: Workflow for Integrating POCUS Data into EHR for Managing Heart Failure Patients

Published on: July 12, 2024

1.0K
A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis18:11

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis

Published on: December 28, 2012

24.6K

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
160
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
221
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
250
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
114
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
200
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
332